Danaher (Beckman Coulter, Leica Biosystems, Radiometer, Cepheid): FDA 510(k) clearances across all its applicant names

FDA lists 1,103 510(k) clearances, 6 PMA and 4 De Novo decisions across the 34 applicant names Caduvo groups under Danaher (Beckman Coulter, Leica Biosystems, Radiometer, Cepheid), first 1976, latest 2026. Median 510(k) review time across these names: 68 days. Since 2017 the median was 147 days, against 171 days for all cleared 510(k)s in the same product codes. Groups are curated by Caduvo from public sources listed below; FDA does not group applicants. Counts include filings made before an acquisition, and can include older filings by a business that was later sold when FDA records them under the same applicant name; see the notes on this page.

510(k) clearances per year

YearClearancesMedian review days
201211113
201314177
201416116
20158130
20161090
201715164
2018991
201916105
2020890
20212215
20227174
202322250
20242488
202517219
202620128

The 34 FDA applicant names in this group

Applicant name510(k) clearancesPMADe NovoYears
Beckman Instruments, Inc.281001976–1998
Beckman Coulter, Inc.280511993–2026
Coulter Electronics, Inc.101001976–1994
Cepheid63032006–2026
Hybritech, Inc.63001981–1997
Coulter Corp.51001989–2000
Radiometer America, Inc.50001983–2016
Dade Microscan, Inc.40001996–2005
Immunotech Corp.40001980–1995
Radiometer Medical Aps28002004–2017
Coulter Immunology16001988–1993
Beckman-Diagnostic Systems Group11001993–1994
Microscan Div. Baxter Healthcare Corp.11001987–1987
Hemocue, Inc.9001991–2004
Beckman Coulter Ireland, Inc.7002013–2019
Beckman6001989–1999
Hemocue AB6002006–2020
Leica Biosystems Newcastle, Ltd.6002014–2023
Aperio Technologies5002007–2009
Leica Biosystems Imaging, Inc.5002014–2026
Radiometer Medicals Aps5002024–2026
Olympus Diagnostica GmbH4001998–2000
Iris International, Inc.3002005–2010
Beckman Coulter Laboratory Systems (Suzhou) Co., Ltd.2002023–2023
Radiometer Medical A/S2002000–2000
Beckman Analytical and Biotechnology Development1001994–1994
Beckman Coulter Biomedical GmbH1002019–2019
Beckman Coulter Cellular1002010–2010
Immunotech S.A.1001993–1993
Immunotech S.R.O.1002019–2019
Iris International Inc., A Division of Iris Iris I1002011–2011
Leica Biosystems Richmond1002014–2014
Radiometer Basel AG1002007–2007
Leica Biosystems010—

Review time against the same product codes

Since 2017, 510(k)s cleared under these names took a median 147 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 171 days.

Top product codes

Product codeDeviceSubmissions510(k) clearances
GKZCounter, Differential Cell8686
JWYManual Antimicrobial Susceptibility Test Systems3838
CHLElectrode Measurement, Blood-Gases (Pco2, Po2) And Blood Ph3131
JPKMixture, Hematology Quality Control2424
GKLCounter, Cell, Automated (Particle Counter)2222
LTTPanels, Test, Susceptibility, Antimicrobial2222
JJYMulti-Analyte Controls, All Kinds (Assayed)2121
JJXSingle (Specified) Analyte Controls (Assayed And Unassayed)2020
JHIVisual, Pregnancy Hcg, Prescription Use1717
JJEAnalyzer, Chemistry (Photometric, Discrete), For Clinical Use1616

Plus 307 more product codes.

Review panels

Most recent Danaher (Beckman Coulter, Leica Biosystems, Radiometer, Cepheid) 510(k) clearances

510(k)DeviceApplicant nameProduct codeDecision dateReview days
K262971Xpert® Hemorrhagic Fever PanelCepheidQVR2026-10-3065
K263333Xpert Xpress CoV-2/Flu plusCepheidQOF2026-10-2230
K262597Access BNP IIBeckman Coulter, Inc.NBC2026-10-2085
K261109Access MeMed BVBeckman Coulter, Inc.QPS2026-10-19199
K263120Xpert Xpress CoV-2/Flu plusCepheidQOF2026-10-0228
K261336Xpert Respiratory PanelCepheidQOF2026-09-25155
K262109Access NT-proBNPBeckman Coulter, Inc.NBC2026-09-2190
K261362Xpert Hemorrhagic FeverCepheidQVR2026-08-07102
K253561Aperio iQC DX SoftwareLeica Biosystems Imaging, Inc.SIX2026-08-07263
K253554Aperio GT 450 DX; Aperio GT 180 DXLeica Biosystems Imaging, Inc.PSY2026-08-07266

1,093 earlier clearances. See the full list in Caduvo.

PMA and De Novo decisions

NumberPathwayDeviceDecision date
P230015PMAAccess HBsAg, Access HBsAg Confirmatory, Access HBsAg Calibrator, Access HBsAg QC2025-10-17
DEN240016De NovoSimple Point-Of-Care Nucleic Acid-Based Hepatitis C Virus Ribonucleic Acid Test2024-06-27
DEN160047De NovoFlow Cytometric Test System For Hematopoietic Neoplasms2017-06-29
DEN130032De NovoSystem, Nucleic Acid-Based, Mycobacterium Tuberculosis Complex, Resistance Marker, Direct Specimen2013-07-25
P090026PMAACCESS HYBRITECH P2PSA ON THE ACCESS IMMUNOASSAY SYSTEMS2012-06-14

Recalls

787 product recalls in 530 recall events under these names; 129 initiated in the last five years.

21 product recalls in 10 recall events filed under other recalling-firm names cite a 510(k) or PMA held under these applicant names; 12 initiated in the last five years. Most often: Remel Inc (9), Hemo Cue, Inc. (3), Tosoh Bioscience Inc (3).

These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.

Recalling firms are matched to the applicant names above by name only, so recalls filed under other names are not counted. A recall count says nothing about how safe one company's devices are compared with another's.

Device clinical trials

ClinicalTrials.gov lists 16 device studies (0 active or recruiting) with an industry lead sponsor under the 3 sponsor names below. Most recent:

Lead sponsor name on ClinicalTrials.govDevice studies
Radiometer Medical ApS9
Beckman Coulter, Inc.4
Cepheid3

Sponsor names are matched to the applicant names above by name, with punctuation and legal suffixes removed, plus sponsor names reviewed for this group. Studies listed under other sponsor names are not counted.

Parent company SEC filings

DANAHER CORP /DE/ (DHR): EDGAR filings, CIK 313616. The parent's SEC registrant is entered by hand for this group, not matched by name.

How this group is built

Groups are curated by Caduvo from public sources listed below; FDA does not group applicants. Counts include filings made before an acquisition, and can include older filings by a business that was later sold when FDA records them under the same applicant name; see the notes on this page.

Radiometer (2004), Leica (2005), HemoCue (2013 via Radiometer), Beckman Coulter (2011; Beckman had merged with Coulter 1997 and bought Hybritech and Immunotech), IRIS International (2012), Cepheid (2016), MicroScan (from Siemens, 2018) and Olympus's lab-diagnostics business (2009). Includes filings made before each acquisition. Left out: Leica Microsystems (microscopy), dental businesses (spun off as Envista 2019).

Sources

Frequently asked questions

How many FDA 510(k) clearances are listed across Danaher (Beckman Coulter, Leica Biosystems, Radiometer, Cepheid)'s applicant names?

FDA lists 1,103 510(k) clearances, 6 PMA and 4 De Novo decisions across the 34 applicant names Caduvo groups under Danaher (Beckman Coulter, Leica Biosystems, Radiometer, Cepheid), first 1976, latest 2026. FDA records each applicant name separately; Caduvo adds up the names listed on this page.

Which FDA applicant names does Danaher (Beckman Coulter, Leica Biosystems, Radiometer, Cepheid) file under?

The names with the most 510(k) clearances in this group are Beckman Instruments, Inc. (281); Beckman Coulter, Inc. (280); Coulter Electronics, Inc. (101); Cepheid (63); Hybritech, Inc. (63). The full list of 34 names is on this page.

How long does FDA take to clear Danaher (Beckman Coulter, Leica Biosystems, Radiometer, Cepheid) 510(k)s?

The median time from FDA receipt to decision across 510(k)s cleared under these names is 68 days. Since 2017 the median was 147 days, against 171 days for all cleared 510(k)s in the same product codes.

Does the Danaher (Beckman Coulter, Leica Biosystems, Radiometer, Cepheid) count include acquired companies?

Yes. A group includes filings an acquired business made under its own name, including before the acquisition. Businesses that were sold are left out, and names whose ownership is unclear are not included. FDA does not group applicants; the sources for each grouping are listed on this page.

How many device clinical trials does Danaher (Beckman Coulter, Leica Biosystems, Radiometer, Cepheid) sponsor?

ClinicalTrials.gov lists 16 device studies (0 active or recruiting) with an industry lead sponsor under 3 sponsor names Caduvo groups under Danaher (Beckman Coulter, Leica Biosystems, Radiometer, Cepheid). ClinicalTrials.gov names the sponsor on each study; Caduvo adds up the names listed on this page.

Next steps

Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this grouping or data. Data and corrections policy.

All parent companies · FDA device companies by applicant name · FDA product code lookup